论文信息 - Findings from the phase I clinical trials of CX-4945, an orally available inhibitor of CK2. - 字舞流文

Findings from the phase I clinical trials of CX-4945, an orally available inhibitor of CK2.

M. Borad | D. V. Von Hoff | D. Northfelt | S. O'Brien | R. Marschke | C. Padgett | R. McFarland | R. H. Alvarez | J. K. Lim | J. K. Lim